Reuters logo
3 个月前
BRIEF-Vical reports outcome of Phase 1 trial of VL-2397
2017年5月2日 / 晚上10点03分 / 3 个月前

BRIEF-Vical reports outcome of Phase 1 trial of VL-2397

1 分钟阅读

May 2 (Reuters) - Vical Inc

* Vical highlights successful outcome of Phase 1 trial of VL-2397 novel antifungal during its research and development day Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below